デフォルト表紙
市場調査レポート
商品コード
1470736

ラテラルフローアッセイ市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、予測、2024-2031年

Lateral Flow Assay Market by Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 419 Pages
納期
2～5営業日
カスタマイズ可能
ラテラルフローアッセイ市場：地域別（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）：世界の産業分析、規模、シェア、成長、動向、予測、2024-2031年
出版日: 2024年04月25日
発行: Persistence Market Research
ページ情報: 英文 419 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

Persistence Market Research社は、世界のラテラルフローアッセイ市場の包括的な分析を発表し、その成長要因、課題、新たな動向に関する深い洞察を提供します。この詳細なレポートでは、2024年から2031年までの市場の進展を予測する独自のデータと統計を提供しています。

主な洞察

  • ラテラルフローアッセイの市場規模（2024E）：91億米ドル
  • 予測市場価値（2031F）：124億米ドル
  • 世界市場成長率（CAGR 2024年～2031年）：4.50%

ラテラルフローアッセイ市場：調査範囲

迅速診断法であるラテラルフローアッセイは、ヘルスケア、食品安全、動物診断、環境検査など様々な産業で極めて重要な役割を果たしています。ラテラル・フロー・アッセイは、その簡便性、迅速性、費用対効果を活かし、ポイント・オブ・ケア検査、在宅診断、オンサイト・スクリーニングに幅広く応用されています。

世界のラテラルフローアッセイ市場は、感染症の流行増加、迅速診断ソリューションに対する需要の高まり、アッセイ技術の進歩などの要因によって大きく成長しています。さらに、食品安全や環境モニタリングなど、ヘルスケア以外にもラテラルフローアッセイの用途が拡大していることが、市場成長をさらに後押ししています。

市場成長の促進要因：

世界の感染症罹患率の上昇と、迅速かつ正確な診断ソリューションの必要性が、ヘルスケア分野におけるラテラルフローアッセイの需要を牽引しています。さらに、ラテラル・フロー・アッセイプラットフォームの技術的進歩により、感度、特異性、多重化機能が強化され、多様なアプリケーションでの有用性が高まっています。さらに、食品の安全性と環境モニタリングの重要性に関する意識の高まりが、これらの分野におけるラテラルフローアッセイの需要を促進し、市場の成長に寄与しています。

市場抑制要因：

大きな成長の見込みがあるにもかかわらず、世界のラテラルフローアッセイ市場は、従来のアッセイの感度や特異度が限定的であるため、偽陽性や偽陰性の結果につながるなどの課題に直面しています。これらの限界に対処するには、アッセイコンポーネントの継続的な革新と最適化が必要であり、技術的・規制的なハードルとなる可能性があります。

さらに、ラテラルフローアッセイ市場の競合情勢は、類似製品を提供する多数のプレイヤーの存在によって特徴付けられ、価格競争とマージン圧力が激化しています。さらに、製品のバリデーションと承認に関する厳しい規制要件が、特に新規参入企業や小規模メーカーにとって、市場参入を複雑なものにしています。

市場機会：

マイクロフルイディクス、デジタルイメージング、スマートフォンベースの検出の統合など、アッセイ技術の進歩が進んでおり、ラテラルフローアッセイ分野における技術革新と市場拡大の好機となっています。さらに、新興経済諸国では、医療費の増加、ヘルスケアインフラの改善、感染症に対する意識の高まりなどを背景に、ラテラルフローアッセイの採用が増加しており、大きな成長の可能性を秘めています。さらに、診断薬企業、研究機関、政府機関の間の提携や協力関係は、未開拓地域における技術移転、能力開発、市場参入を促進します。

本レポートで扱う主な質問

  • ラテラルフローアッセイ市場の成長を牽引するセグメントとアプリケーションは何か？
  • ラテラルフローアッセイの将来を形作る主な技術的進歩やイノベーションは何か？
  • 規制の枠組みや償還政策は市場ダイナミクスや競争にどのような影響を与えるのか？
  • 市場の優位性と競合を維持するための主要プレーヤーとその戦略とは？
  • 世界のラテラルフローアッセイ市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 製品の採用/使用状況分析
  • 製品のUSP/特徴
  • 主なプロモーション戦略
  • 規制シナリオ
  • PESTLE分析
  • ポーターの分析
  • 地域疫学
  • 最近の製品の発売と承認

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 世界のラテラルフローアッセイ市場-COVID-19危機- 影響評価

  • 現在の統計と将来の影響の可能性
  • COVID-19の影響
  • セグメント別影響分析

第7章 世界のラテラルフローアッセイ市場- 価格分析

  • 製品タイプ別の地域別価格分析
  • 世界平均価格分析ベンチマーク

第8章 世界のラテラルフローアッセイ市場（数量）分析

  • 過去の市場規模（数量）分析、2012～2023年
  • 現在および将来の市場規模（数量）予測、2024～2031年
    • 前年比成長動向分析

第9章 世界のラテラルフローアッセイ市場（金額および規模）分析

  • 過去の市場金額（金額）分析、2012～2023年
  • 現在および将来の市場金額（金額）予測、2024～2031年
    • 前年比成長動向分析
    • 絶対的収益の機会分析

第10章 世界のラテラルフローアッセイ市場分析、製品タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）と数量分析、2012～2023年
  • 現在および将来の市場規模（金額）と数量分析・予測、2024～2031年
    • リーダー
      • ベンチトップリーダー
      • ハンドヘルドリーダー
    • LFAキット
      • テストストリップ
      • ディップスティック
      • カセット
      • ランセット
  • 製品タイプ別の市場魅力度分析

第11章世界のラテラルフローアッセイ市場分析、 アプリケーション別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）と数量分析、2012～2023年
  • 現在および将来の市場規模（金額）と数量分析・予測、2024～2031年
    • 性感染症
      • ヒト欠損ウイルス（HIV）感染症
      • 淋病
      • 梅毒
      • その他
    • 感染症
      • 蚊媒介性疾患
      • 連鎖球菌感染症
      • 肝炎感染
      • 胃腸感染症
      • 呼吸器感染症
      • その他
    • 糖尿病
    • 妊娠と生殖能力の検査
    • 薬物乱用検査
  • アプリケーション別の市場魅力度分析

第12章 世界のラテラルフローアッセイ市場分析、流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）と数量分析、2012～2023年
  • 現在および将来の市場規模（金額）と数量分析・予測、2024～2031年
    • 病院薬局
    • 小売薬局
    • スーパーマーケット/ハイパーマーケット
    • eコマース
  • アプリケーション別の市場魅力度分析

第13章 ラテラルフローアッセイ市場分析、地域別

  • イントロダクション
  • 過去の市場規模（金額）と数量分析、2012～2023年
  • 現在および将来の市場規模（金額）と数量分析・予測、2024～2031年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（MEA）
  • 地域別市場魅力度分析

第14章 北米ラテラルフローアッセイ市場分析

第15章 ラテンアメリカのラテラルフローアッセイ市場分析

第16章 欧州のラテラルフローアッセイ市場分析

第17章 南アジアのラテラルフローアッセイ市場分析

第18章 東アジアのラテラルフローアッセイ市場分析

第19章 オセアニアのラテラルフローアッセイ市場分析

第20章 中東およびアフリカのラテラルフローアッセイ市場分析

第21章 市場構造分析

  • 企業階層別市場分析（ラテラルフローアッセイ）
  • 主要企業の市場シェア分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche
    • Abbott Laboratories
    • Becton, Dickinson &Company
    • PerkinElmer Inc.
    • Siemens Healthineers
    • QIAGEN NV
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Maternova Inc.
    • Quidel Corporation
    • Healgen Scientific, LLC.
    • Meridian Bioscience Inc.
    • Abcam plc.
    • Access Bio, Inc.
    • Humasis Co. Ltd.
    • DIALUNOX GmbH
    • Detekt Biomedical LLC
    • Guangzhou Wondfo Biotech Co., Ltd.
    • Creative Diagnostics

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP18613

Persistence Market Research unveils a comprehensive analysis of the global lateral flow assay market, providing deep insights into its growth trajectory, challenges, and emerging trends. This detailed report offers exclusive data and statistics forecasting the market's progression from 2024 to 2031.

Key Insights:

  • Lateral Flow Assay Market Size (2024E): US$ 9.1 Billion
  • Projected Market Value (2031F): US$ 12.4 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 4.50%

Lateral Flow Assay Market - Report Scope:

Lateral flow assay, a rapid diagnostic method, plays a pivotal role in various industries, including healthcare, food safety, veterinary diagnostics, and environmental testing. Utilizing its simplicity, speed, and cost-effectiveness, lateral flow assays find extensive application in point-of-care testing, home diagnostics, and on-site screening.

The global lateral flow assay market experiences substantial growth driven by factors such as the increasing prevalence of infectious diseases, the rising demand for rapid diagnostic solutions, and advancements in assay technologies. Moreover, the expanding applications of lateral flow assays beyond healthcare, such as in food safety and environmental monitoring, further propel market growth.

Market Growth Drivers:

The escalating incidence of infectious diseases worldwide, coupled with the need for rapid and accurate diagnostic solutions, drives the demand for lateral flow assays in the healthcare sector. With the emergence of novel pathogens and the persistence of endemic diseases, there is a growing emphasis on early detection and prompt intervention, fueling the adoption of lateral flow assays.Furthermore, technological advancements in lateral flow assay platforms enhance their sensitivity, specificity, and multiplexing capabilities, widening their utility across diverse applications. Additionally, the increasing awareness regarding the importance of food safety and environmental monitoring drives the demand for lateral flow assays in these sectors, contributing to market growth.

Market Restraints:

Despite the significant growth prospects, the global lateral flow assay market faces challenges such as the limited sensitivity and specificity of conventional assays, leading to false-positive or false-negative results. Addressing these limitations requires continuous innovation and optimization of assay components, which may pose technical and regulatory hurdles.

Moreover, the competitive landscape of the lateral flow assay market is characterized by the presence of numerous players offering similar products, intensifying price competition and margin pressures. Additionally, stringent regulatory requirements for product validation and approval add complexity to market entry, particularly for new entrants and small-scale manufacturers.

Market Opportunities:

The ongoing advancements in assay technologies, including the integration of microfluidics, digital imaging, and smartphone-based detection, present lucrative opportunities for innovation and market expansion in the lateral flow assay segment. These developments enable enhanced sensitivity, quantitative analysis, and connectivity, catering to the evolving needs of end-users across various industries.Furthermore, the increasing adoption of lateral flow assays in emerging economies, driven by rising healthcare expenditure, improving healthcare infrastructure, and growing awareness about infectious diseases, offers significant growth potential. Additionally, partnerships and collaborations between diagnostic companies, research institutions, and government agencies facilitate technology transfer, capacity building, and market access in untapped regions.

Key Questions Answered in the Report:

  • Which segments and applications are driving the growth of the lateral flow assay market?
  • What are the key technological advancements and innovations shaping the future of lateral flow assays?
  • How do regulatory frameworks and reimbursement policies influence market dynamics and competition?
  • Who are the leading players and what are their strategies to maintain market dominance and competitiveness?
  • What are the emerging trends and future prospects in the global lateral flow assay market?

Competitive Intelligence and Business Strategy:

To stay ahead in the competitive landscape, key players in the lateral flow assay market focus on product innovation, strategic partnerships, and geographic expansion. Companies such as Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Danaher Corporation invest in research and development to launch next-generation lateral flow assay platforms with improved performance and usability. Moreover, strategic collaborations with healthcare providers, distribution partners, and regulatory agencies enable companies to penetrate new markets, enhance customer reach, and navigate regulatory challenges effectively. In summary, a combination of innovation, collaboration, and market diversification strategies ensures sustained growth and competitiveness in the dynamic lateral flow assay market.

Key Companies Profiled:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • PerkinElmer, Inc.

Lateral Flow Assay Market Research Segmentation:

Lateral Flow Assay Market by Product Type:

  • LFA Readers
  • Benchtop Readers
  • Handheld Readers
  • LFA Kits
  • Test Strips
  • Dipsticks
  • Cassettes
  • Lancets

Lateral Flow Assay Market by Application:

  • Sexually Transmitted Diseases
  • Human Deficiency Virus (HIV) Infection
  • Gonorrhoea
  • Syphilis
  • Others
  • Infectious Diseases
  • Mosquito-Borne Diseases
  • Streptococcus Infections
  • Hepatitis Infection
  • Gastrointestinal Infections
  • Respiratory Tract Infections
  • Others
  • Diabetes
  • Pregnancy and Fertility Testing
  • Drug of Abuse Testing

Lateral Flow Assay Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Supermarkets/Hypermarkets
  • e-Commerce

Lateral Flow Assay Market by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Technology Roadmap
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Key Promotional Strategies
  • 4.4. Regulatory Scenario
  • 4.5. PESTLE Analysis
  • 4.6. Porter's Analysis
  • 4.7. Regional Epidemiology
  • 4.8. Recent Product Launches and Approvals

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Increasing Spending on Healthcare Per Capita
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Growing Usage of Home-based Lateral Flow Assay Devices
    • 5.2.3. Increasing Global Prevalence of Acute and Chronic Infectious Diseases
    • 5.2.4. Rising Geriatric Population
    • 5.2.5. Entry of Domestic Players into the Market
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Lateral Flow Assay Market- COVID-19 Crisis - Impact Assessment

  • 6.1. Current Statistics and Probable Future Impact
  • 6.2. Impact of COVID-19
  • 6.3. Impact Analysis, By segment

7. Global Lateral Flow Assay Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product Type
  • 7.2. Global Average Pricing Analysis Benchmark

8. Global Lateral Flow Assay Market Volume (in 000 Units) Analysis 2012-2023 and Forecast, 2024-2031

  • 8.1. Historical Market Volume (in 000 Units) Analysis, 2012-2023
  • 8.2. Current and Future Market Volume (in 000 Units) Projections, 2024-2031
    • 8.2.1. Y-o-Y Growth Trend Analysis

9. Global Lateral Flow Assay Market (in Value or Size in US$ Mn) Analysis 2012-2023 and Forecast, 2024-2031

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2012-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Product Type

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2012-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2024-2031
    • 10.3.1. Readers
      • 10.3.1.1. Bench-Top Readers
      • 10.3.1.2. Hand-held Readers
    • 10.3.2. LFA Kits
      • 10.3.2.1. Test Strips
      • 10.3.2.2. Dipsticks
      • 10.3.2.3. Cassettes
      • 10.3.2.4. Lancets
  • 10.4. Market Attractiveness Analysis By Product Type

11. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 11.3.1. Sexually Transmitted Diseases
      • 11.3.1.1. Human Deficiency Virus (HIV) Infection
      • 11.3.1.2. Gonorrhoea
      • 11.3.1.3. Syphilis
      • 11.3.1.4. Others
    • 11.3.2. Infectious Diseases
      • 11.3.2.1. Mosquito-Borne Diseases
      • 11.3.2.2. Streptococcus Infections
      • 11.3.2.3. Hepatitis Infection
      • 11.3.2.4. Gastrointestinal Infections
      • 11.3.2.5. Respiratory Tract Infections
      • 11.3.2.6. Others
    • 11.3.3. Diabetes
    • 11.3.4. Pregnancy and Fertility Testing
    • 11.3.5. Drug of Abuse Testing
  • 11.4. Market Attractiveness Analysis By Application

12. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Application, 2012-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Supermarket/Hypermarket
    • 12.3.4. E-Commerce
  • 12.4. Market Attractiveness Analysis By Application

13. Global Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2023
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product Type
    • 14.3.3. By Application
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product Type
    • 14.4.3. By Application
    • 14.4.4. By Distribution Channel
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. U.S. Lateral Flow Assay Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product Type
        • 14.5.1.2.2. By Application
        • 14.5.1.2.3. By Distribution Channel
    • 14.5.2. Canada Lateral Flow Assay Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product Type
        • 14.5.2.2.2. By Application
        • 14.5.2.2.3. By Distribution Channel
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis

15. Latin America Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product Type
    • 15.3.3. By Application
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product Type
    • 15.4.3. By Application
    • 15.4.4. By Distribution Channel
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. Brazil Lateral Flow Assay Analysis
      • 15.5.1.1. .Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product Type
        • 15.5.1.2.2. By Application
        • 15.5.1.2.3. By Distribution Channel
    • 15.5.2. Mexico Lateral Flow Assay Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product Type
        • 15.5.2.2.2. By Application
        • 15.5.2.2.3. By Distribution Channel
    • 15.5.3. Argentina Lateral Flow Assay Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product Type
        • 15.5.3.2.2. By Application
        • 15.5.3.2.3. By Distribution Channel
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis

16. Europe Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. France
      • 16.3.1.3. Italy
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. Russia
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. BENELUX
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product Type
    • 16.3.3. By Application
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product Type
    • 16.4.3. By Application
    • 16.4.4. By Distribution Channel
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Germany Lateral Flow Assay Analysis
      • 16.5.1.1. .Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product Type
        • 16.5.1.2.2. By Application
        • 16.5.1.2.3. By Distribution Channel
    • 16.5.2. France Lateral Flow Assay Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product Type
        • 16.5.2.2.2. By Application
        • 16.5.2.2.3. By Distribution Channel
    • 16.5.3. Italy Lateral Flow Assay Analysis
      • 16.5.3.1. Introduction
      • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.3.2.1. By Product Type
        • 16.5.3.2.2. By Application
        • 16.5.3.2.3. By Distribution Channel
    • 16.5.4. U.K. Lateral Flow Assay Analysis
      • 16.5.4.1. .Introduction
      • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.4.2.1. By Product Type
        • 16.5.4.2.2. By Application
        • 16.5.4.2.3. By Distribution Channel
    • 16.5.5. Spain Lateral Flow Assay Analysis
      • 16.5.5.1. .Introduction
      • 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.5.2.1. By Product Type
        • 16.5.5.2.2. By Application
        • 16.5.5.2.3. By Distribution Channel
    • 16.5.6. Russia Lateral Flow Assay Analysis
      • 16.5.6.1. .Introduction
      • 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.6.2.1. By Product Type
        • 16.5.6.2.2. By Application
        • 16.5.6.2.3. By Distribution Channel
    • 16.5.7. Nordic Countries Lateral Flow Assay Analysis
      • 16.5.7.1. .Introduction
      • 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.7.2.1. By Product Type
        • 16.5.7.2.2. By Application
        • 16.5.7.2.3. By Distribution Channel
    • 16.5.8. BENELUX Lateral Flow Assay Analysis
      • 16.5.8.1. .Introduction
      • 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.8.2.1. By Product Type
        • 16.5.8.2.2. By Application
        • 16.5.8.2.3. By Distribution Channel
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis

17. South Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Philippines
      • 17.3.1.5. Thailand
      • 17.3.1.6. Vietnam
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product Type
    • 17.3.3. By Application
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product Type
    • 17.4.3. By Application
    • 17.4.4. By Distribution Channel
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. India Lateral Flow Assay Analysis
      • 17.5.1.1. .Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product Type
        • 17.5.1.2.2. By Application
        • 17.5.1.2.3. By Distribution Channel
    • 17.5.2. Indonesia Lateral Flow Assay Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product Type
        • 17.5.2.2.2. By Application
        • 17.5.2.2.3. By Distribution Channel
    • 17.5.3. Malaysia Lateral Flow Assay Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product Type
        • 17.5.3.2.2. By Application
        • 17.5.3.2.3. By Distribution Channel
    • 17.5.4. Philippines Lateral Flow Assay Analysis
      • 17.5.4.1. .Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Product Type
        • 17.5.4.2.2. By Application
        • 17.5.4.2.3. By Distribution Channel
    • 17.5.5. Thailand Lateral Flow Assay Analysis
      • 17.5.5.1. .Introduction
      • 17.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.5.2.1. By Product Type
        • 17.5.5.2.2. By Application
        • 17.5.5.2.3. By Distribution Channel
    • 17.5.6. Vietnam Lateral Flow Assay Analysis
      • 17.5.6.1. .Introduction
      • 17.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.6.2.1. By Product Type
        • 17.5.6.2.2. By Application
        • 17.5.6.2.3. By Distribution Channel
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis

18. East Asia Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 18.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product Type
    • 18.3.3. By Application
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product Type
    • 18.4.3. By Application
    • 18.4.4. By Distribution Channel
  • 18.5. Country Level Analysis & Forecast
    • 18.5.1. China Lateral Flow Assay Analysis
      • 18.5.1.1. .Introduction
      • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.1.2.1. By Product Type
        • 18.5.1.2.2. By Application
        • 18.5.1.2.3. By Distribution Channel
    • 18.5.2. Japan Lateral Flow Assay Analysis
      • 18.5.2.1. Introduction
      • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.2.2.1. By Product Type
        • 18.5.2.2.2. By Application
        • 18.5.2.2.3. By Distribution Channel
    • 18.5.3. South Korea Lateral Flow Assay Analysis
      • 18.5.3.1. Introduction
      • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.5.3.2.1. By Product Type
        • 18.5.3.2.2. By Application
        • 18.5.3.2.3. By Distribution Channel
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis

19. Oceania Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 19.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product Type
    • 19.3.3. By Application
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product Type
    • 19.4.3. By Application
    • 19.4.4. By Distribution Channel
  • 19.5. Country Level Analysis & Forecast
    • 19.5.1. Australia Lateral Flow Assay Analysis
      • 19.5.1.1. .Introduction
      • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.1.2.1. By Product Type
        • 19.5.1.2.2. By Application
        • 19.5.1.2.3. By Distribution Channel
    • 19.5.2. New Zealand Lateral Flow Assay Analysis
      • 19.5.2.1. Introduction
      • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.5.2.2.1. By Product Type
        • 19.5.2.2.2. By Application
        • 19.5.2.2.3. By Distribution Channel
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Lateral Flow Assay Market Analysis 2012-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2012-2023
  • 20.3. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
    • 20.3.1. By Country
      • 20.3.1.1. Turkey
      • 20.3.1.2. GCC Countries
      • 20.3.1.3. Northern Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Application
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product Type
    • 20.4.3. By Application
    • 20.4.4. By Distribution Channel
  • 20.5. Country Level Analysis & Forecast
    • 20.5.1. Turkey Lateral Flow Assay Analysis
      • 20.5.1.1. Introduction
      • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.1.2.1. By Product Type
        • 20.5.1.2.2. By Application
        • 20.5.1.2.3. By Distribution Channel
    • 20.5.2. GCC Countries Lateral Flow Assay Analysis
      • 20.5.2.1. Introduction
      • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.2.2.1. By Product Type
        • 20.5.2.2.2. By Application
        • 20.5.2.2.3. By Distribution Channel
    • 20.5.3. Northern Africa Lateral Flow Assay Analysis
      • 20.5.3.1. Introduction
      • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.3.2.1. By Product Type
        • 20.5.3.2.2. By Application
        • 20.5.3.2.3. By Distribution Channel
    • 20.5.4. South Africa Lateral Flow Assay Analysis
      • 20.5.4.1. Introduction
      • 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.5.4.2.1. By Product Type
        • 20.5.4.2.2. By Application
        • 20.5.4.2.3. By Distribution Channel
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies (Lateral Flow Assay)
  • 21.2. Market Share Analysis of Top Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Thermo Fisher Scientific Inc.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Strategy Overview
      • 22.3.1.5. Key Financials
      • 22.3.1.6. SWOT analysis
    • 22.3.2. F. Hoffmann-La Roche
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Strategy Overview
      • 22.3.2.5. Key Financials
      • 22.3.2.6. SWOT analysis
    • 22.3.3. Abbott Laboratories
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Strategy Overview
      • 22.3.3.5. Key Financials
      • 22.3.3.6. SWOT analysis
    • 22.3.4. Becton, Dickinson & Company
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Strategy Overview
      • 22.3.4.5. Key Financials
      • 22.3.4.6. SWOT analysis
    • 22.3.5. PerkinElmer Inc.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Strategy Overview
      • 22.3.5.5. Key Financials
      • 22.3.5.6. SWOT analysis
    • 22.3.6. Siemens Healthineers
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Strategy Overview
      • 22.3.6.5. Key Financials
      • 22.3.6.6. SWOT analysis
    • 22.3.7. QIAGEN N.V.
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Strategy Overview
      • 22.3.7.5. Key Financials
      • 22.3.7.6. SWOT analysis
    • 22.3.8. bioMerieux SA
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Strategy Overview
      • 22.3.8.5. Key Financials
      • 22.3.8.6. SWOT analysis
    • 22.3.9. Bio-Rad Laboratories, Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Strategy Overview
      • 22.3.9.5. Key Financials
      • 22.3.9.6. SWOT analysis
    • 22.3.10. Maternova Inc.
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Strategy Overview
      • 22.3.10.5. Key Financials
      • 22.3.10.6. SWOT analysis
    • 22.3.11. Quidel Corporation
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Strategy Overview
      • 22.3.11.5. Key Financials
      • 22.3.11.6. SWOT analysis
    • 22.3.12. Healgen Scientific, LLC.
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Strategy Overview
      • 22.3.12.5. Key Financials
      • 22.3.12.6. SWOT analysis
    • 22.3.13. Meridian Bioscience Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Strategy Overview
      • 22.3.13.5. Key Financials
      • 22.3.13.6. SWOT analysis
    • 22.3.14. Abcam plc.
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Strategy Overview
      • 22.3.14.5. Key Financials
      • 22.3.14.6. SWOT analysis
    • 22.3.15. Access Bio, Inc.
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Sales Footprint
      • 22.3.15.4. Strategy Overview
      • 22.3.15.5. Key Financials
      • 22.3.15.6. SWOT analysis
    • 22.3.16. Humasis Co. Ltd.
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Sales Footprint
      • 22.3.16.4. Strategy Overview
      • 22.3.16.5. Key Financials
      • 22.3.16.6. SWOT analysis
    • 22.3.17. DIALUNOX GmbH
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Sales Footprint
      • 22.3.17.4. Strategy Overview
      • 22.3.17.5. Key Financials
      • 22.3.17.6. SWOT analysis
    • 22.3.18. Detekt Biomedical LLC
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Sales Footprint
      • 22.3.18.4. Strategy Overview
      • 22.3.18.5. Key Financials
      • 22.3.18.6. SWOT analysis
    • 22.3.19. Guangzhou Wondfo Biotech Co., Ltd.
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Sales Footprint
      • 22.3.19.4. Strategy Overview
      • 22.3.19.5. Key Financials
      • 22.3.19.6. SWOT analysis
    • 22.3.20. Creative Diagnostics
      • 22.3.20.1. Overview
      • 22.3.20.2. Product Portfolio
      • 22.3.20.3. Sales Footprint
      • 22.3.20.4. Strategy Overview
      • 22.3.20.5. Key Financials
      • 22.3.20.6. SWOT analysis

23. Assumptions and Acronyms Used

24. Research Methodology